← FDA Drug Approvals (Drugs@FDA)

RELENZA

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1999-07-26

Drug application

FDA Application #

NDA021036

Application type

New Drug Application

Brand name

RELENZA

Generic name

ZANAMIVIR

Active ingredients

ZANAMIVIR

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE

Manufacturer

GlaxoSmithKline LLC

First approval

1999-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown